日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Targeting T cells with tetravalent bispecific antibodies for the treatment of graft-versus-host disease

利用四价双特异性抗体靶向T细胞治疗移植物抗宿主病

Madelyn Espinosa-Cotton ,Sayed Shahabuddin Hoseini ,Ileana C Miranda ,John Herrick ,Nai-Kong V Cheung

Heterodimerization of T cell engaging bispecific antibodies to enhance specificity against pancreatic ductal adenocarcinoma

细胞结合双特异性抗体的异二聚化增强对胰腺导管腺癌的特异性

Alan W Long, Hong Xu, Brian H Santich, Hongfen Guo, Sayed Shahabuddin Hoseini, Elisa de Stanchina, Nai-Kong V Cheung

T cell engaging bispecific antibodies targeting CD33 IgV and IgC domains for the treatment of acute myeloid leukemia

用于治疗急性髓系白血病的靶向 CD33 IgV 和 IgC 结构域的 T 细胞结合双特异性抗体

Sayed Shahabuddin Hoseini ,Mallika Vadlamudi ,Madelyn Espinosa-Cotton ,Hoa Tran ,Yi Feng ,Hong-Fen Guo ,Hong Xu ,Irene Cheung ,Nai-Kong V Cheung

Potent antitumor effect of T cells armed with anti-GD2 bispecific antibody

携带抗GD2双特异性抗体的T细胞具有强大的抗肿瘤作用

Miho Nakajima, Hong-Fen Guo, Sayed Shahabuddin Hoseini, Maya Suzuki, Hong Xu, Nai-Kong V Cheung

Overcoming leukemia heterogeneity by combining T cell engaging bispecific antibodies

通过结合 T 细胞结合双特异性抗体克服白血病异质性

Sayed Shahabuddin Hoseini #, Madelyn Espinosa-Cotton #, Hong-Fen Guo, Nai-Kong V Cheung

Silencing Fc Domains in T cell-Engaging Bispecific Antibodies Improves T-cell Trafficking and Antitumor Potency

沉默 T 细胞结合双特异性抗体中的 Fc 结构域可改善 T 细胞运输和抗肿瘤效力

Linlin Wang, Sayed Shahabuddin Hoseini, Hong Xu, Vladimir Ponomarev, Nai-Kong Cheung

Bispecific antibody does not induce T-cell death mediated by chimeric antigen receptor against disialoganglioside GD2

双特异性抗体不会诱导针对二唾液酸神经节苷脂 GD2 的嵌合抗原受体介导的 T 细胞死亡

Sayed Shahabuddin Hoseini, Konstantin Dobrenkov, Dmitry Pankov, Xiaoliang L Xu, Nai-Kong V Cheung